iBio, Inc.

📍 San Diego, United States🗓 Founded 2008👥 58 employees💰 Last funded May 2026
Biotechnology Research🌐 ibioinc.com
Website LinkedIn
iBio is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling with innovative drug discovery platforms, iBio is creating a pipeline of breakthrough antibody treatments to address significant unmet medical needs. Our mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine. For more information, visit www.ibioinc.com
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
2008
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Portugal
1
Italy
1
United States
1
Investor activity2025–2026 · investors recorded per year
2025220261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in iBio, Inc.?
iBio, Inc. has 3 investors on record on gritt.io.
When did iBio, Inc. last raise funding?
The most recent investment in iBio, Inc. recorded on gritt.io was in May 2026.
When was iBio, Inc. founded?
iBio, Inc. was founded in 2008.
What industry is iBio, Inc. in?
iBio, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is iBio, Inc. based?
iBio, Inc. is headquartered in San Diego, United States.